BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 29, 2008
View Archived Issues
Valeant Gets $125M Up Front from GSK in Epilepsy Deal
Valeant Pharmaceuticals International and GlaxoSmithKline plc said they are collaborating on the investigational drug retigabine for epilepsy, a deal that gives Valeant a $125 million up-front payment. (BioWorld Today)
Read More
BDSI's Cancer Pain Patch on Pathway to Approval
Read More
Normal Cells May Contribute to Breast Cancer Metastases
Read More
Further Staff Cuts as Replidyne Reviews Strategic Alternatives
Read More
Holiday Notice
Read More
Clinic Roundup
Read More
Other News To Note
Read More